4DMedical is trading up 10.45% at A$2.69 on November 2, 2026, with the company saying it believes increased short interest is responsible. - The company told the ASX it knew of no unannounced information explaining recent trading. - The ASX temporarily paused trading pending a further announcement; its notice provided no details explaining the move. - The supplied price context shows a sharp rebound after recent declines, but no verified company announcement directly accounts for the rise.